Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Total Current Liabilities: 2015-2025

Historic Total Current Liabilities for Mesoblast (MESO) over the last 8 years, with Jun 2025 value amounting to $102.6 million.

  • Mesoblast's Total Current Liabilities rose 40.12% to $102.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $102.6 million, marking a year-over-year increase of 40.12%. This contributed to the annual value of $102.6 million for FY2025, which is 40.12% up from last year.
  • Per Mesoblast's latest filing, its Total Current Liabilities stood at $102.6 million for Q2 2025, which was up 41.07% from $72.8 million recorded in Q4 2024.
  • Mesoblast's 5-year Total Current Liabilities high stood at $102.6 million for Q2 2025, and its period low was $31.4 million during Q4 2023.
  • Over the past 3 years, Mesoblast's median Total Current Liabilities value was $63.3 million (recorded in 2023), while the average stood at $62.6 million.
  • In the last 5 years, Mesoblast's Total Current Liabilities tumbled by 47.47% in 2022 and then spiked by 131.93% in 2024.
  • Quarterly analysis of 5 years shows Mesoblast's Total Current Liabilities stood at $58.0 million in 2021, then decreased by 5.83% to $54.6 million in 2022, then crashed by 42.53% to $31.4 million in 2023, then spiked by 131.93% to $72.8 million in 2024, then surged by 40.12% to $102.6 million in 2025.
  • Its Total Current Liabilities was $102.6 million in Q2 2025, compared to $72.8 million in Q4 2024 and $73.2 million in Q2 2024.